Performance of Sexually Transmitted Disease Laboratories for Neisseria gonorrhoeae Detection in Southern China From 2020 Through 2022

Abstract

Abstract The rising incidence of gonorrhea presents a global public health challenge, emphasizing the importance of accurate Neisseria gonorrhoeae detection for effective diagnosis, treatment and prevention. This study assessed the performance of sexually transmitted disease laboratories for N. gonorrhoeae detection in Guangdong, southern China. A questionnaire about N. gonorrhoeae detection and external quality assessments (EQAs) with five samples for culture and five for nucleic acid amplification tests (NAATs) were conducted annually from 2020 through 2022. The questionnaire was responded to by 1,047 laboratories, with the results showing that Gram staining and culture were most commonly used by 44.3% and 40.4% of the laboratories, respectively, whereas NAATs were adopted by only 11.7%. The number of clinical samples tested for N. gonorrhoeae increased from 536,369 in 363 laboratories in 2020 to 1,093,147 in 582 laboratories in 2022 (P > 0.05), with an overall male-to-female testing ratio of 1:3.4 and a positive ratio of 3.6:1. The EQA results revealed a concordance rate of 90.8% for gonococcal culture and 93.1% for NAATs. NAATs demonstrated a decreasing detection rate (from 100.0% to 84.5%) with reducing gonococcal DNA copies and 89.0% specificity with the interference-negative sample. The overall concordance rates of four widely used commercial NAAT kits ranged from 95.7% to 88.5%. Gram staining and culture were widely used to detect N. gonorrhoeae in Guangdong. NAAT has long been recognized as a highly sensitive and specific method for detecting gonorrhea and should be widely implemented in China.